vs
BigBear.ai Holdings, Inc.(BBAI)与RECURSION PHARMACEUTICALS, INC.(RXRX)财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是BigBear.ai Holdings, Inc.的1.3倍($35.5M vs $27.3M),RECURSION PHARMACEUTICALS, INC.同比增速更快(681.7% vs -37.7%),BigBear.ai Holdings, Inc.自由现金流更多($-22.1M vs $-47.3M),过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高(60.5% vs -9.2%)
BigBear.ai Holdings, Inc.是一家专注于人工智能决策支持与分析解决方案的服务商,核心产品包括预测分析、供应链优化、运营智能平台,服务国防、情报机构及商业企业客户,主要市场覆盖北美,助力客户提升运营效率、降低运营风险。
Recursion Pharmaceuticals是一家临床阶段生物技术企业,依托人工智能技术和高通量生物实验体系,开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法,核心市场覆盖北美,与全球多家生物制药企业合作推进在研管线落地。
BBAI vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.3倍
$27.3M
营收增速更快
RXRX
高出719.5%
-37.7%
自由现金流更多
BBAI
多$25.2M
$-47.3M
两年增速更快
RXRX
近两年复合增速
-9.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $27.3M | $35.5M |
| 净利润 | — | $-108.1M |
| 毛利率 | 20.3% | 59.8% |
| 营业利润率 | -295.0% | -304.8% |
| 净利率 | — | -304.2% |
| 营收同比 | -37.7% | 681.7% |
| 净利润同比 | — | 39.6% |
| 每股收益(稀释后) | $0.17 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BBAI
RXRX
| Q4 25 | $27.3M | $35.5M | ||
| Q3 25 | $33.1M | $5.2M | ||
| Q2 25 | $32.5M | $19.2M | ||
| Q1 25 | $34.8M | $14.7M | ||
| Q4 24 | $43.8M | $4.5M | ||
| Q3 24 | $41.5M | $26.1M | ||
| Q2 24 | $39.8M | $14.4M | ||
| Q1 24 | $33.1M | $13.8M |
净利润
BBAI
RXRX
| Q4 25 | — | $-108.1M | ||
| Q3 25 | $2.5M | $-162.3M | ||
| Q2 25 | $-228.6M | $-171.9M | ||
| Q1 25 | $-62.0M | $-202.5M | ||
| Q4 24 | — | $-178.9M | ||
| Q3 24 | $-15.1M | $-95.8M | ||
| Q2 24 | $-14.4M | $-97.5M | ||
| Q1 24 | $-127.8M | $-91.4M |
毛利率
BBAI
RXRX
| Q4 25 | 20.3% | 59.8% | ||
| Q3 25 | 22.4% | -183.8% | ||
| Q2 25 | 25.0% | -4.9% | ||
| Q1 25 | 21.3% | -48.0% | ||
| Q4 24 | 37.4% | -181.4% | ||
| Q3 24 | 25.9% | 53.7% | ||
| Q2 24 | 27.8% | 36.2% | ||
| Q1 24 | 21.1% | 19.1% |
营业利润率
BBAI
RXRX
| Q4 25 | -295.0% | -304.8% | ||
| Q3 25 | -66.0% | -3327.6% | ||
| Q2 25 | -278.1% | -916.8% | ||
| Q1 25 | -61.0% | -1297.9% | ||
| Q4 24 | -18.6% | -4042.4% | ||
| Q3 24 | -25.4% | -377.1% | ||
| Q2 24 | -41.9% | -697.4% | ||
| Q1 24 | -296.1% | -698.4% |
净利率
BBAI
RXRX
| Q4 25 | — | -304.2% | ||
| Q3 25 | 7.6% | -3135.3% | ||
| Q2 25 | -704.0% | -894.2% | ||
| Q1 25 | -178.3% | -1373.3% | ||
| Q4 24 | — | -3935.5% | ||
| Q3 24 | -36.5% | -367.5% | ||
| Q2 24 | -36.3% | -676.6% | ||
| Q1 24 | -385.8% | -662.4% |
每股收益(稀释后)
BBAI
RXRX
| Q4 25 | $0.17 | $-0.17 | ||
| Q3 25 | $-0.03 | $-0.36 | ||
| Q2 25 | $-0.71 | $-0.41 | ||
| Q1 25 | $-0.25 | $-0.50 | ||
| Q4 24 | $-0.47 | $-0.56 | ||
| Q3 24 | $-0.06 | $-0.34 | ||
| Q2 24 | $-0.06 | $-0.40 | ||
| Q1 24 | $-0.68 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $87.1M | $743.3M |
| 总债务越低越好 | $107.0M | $9.6M |
| 股东权益账面价值 | $611.9M | $1.1B |
| 总资产 | $894.5M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.17× | 0.01× |
8季度趋势,按日历期对齐
现金及短期投资
BBAI
RXRX
| Q4 25 | $87.1M | $743.3M | ||
| Q3 25 | $456.6M | $659.8M | ||
| Q2 25 | $390.8M | $525.1M | ||
| Q1 25 | $107.6M | $500.5M | ||
| Q4 24 | $50.1M | $594.4M | ||
| Q3 24 | $65.6M | $427.6M | ||
| Q2 24 | $72.3M | $474.3M | ||
| Q1 24 | $81.4M | $296.3M |
总债务
BBAI
RXRX
| Q4 25 | $107.0M | $9.6M | ||
| Q3 25 | $104.9M | $11.9M | ||
| Q2 25 | $103.0M | $14.2M | ||
| Q1 25 | $101.4M | $16.4M | ||
| Q4 24 | $136.2M | $19.0M | ||
| Q3 24 | $195.7M | $20.5M | ||
| Q2 24 | $195.7M | $22.9M | ||
| Q1 24 | $195.6M | — |
股东权益
BBAI
RXRX
| Q4 25 | $611.9M | $1.1B | ||
| Q3 25 | $610.0M | $1.0B | ||
| Q2 25 | $266.6M | $919.1M | ||
| Q1 25 | $197.8M | $933.9M | ||
| Q4 24 | $-3.7M | $1.0B | ||
| Q3 24 | $127.5M | $524.6M | ||
| Q2 24 | $134.7M | $584.4M | ||
| Q1 24 | $143.2M | $401.2M |
总资产
BBAI
RXRX
| Q4 25 | $894.5M | $1.5B | ||
| Q3 25 | $919.8M | $1.4B | ||
| Q2 25 | $599.4M | $1.3B | ||
| Q1 25 | $396.3M | $1.3B | ||
| Q4 24 | $343.8M | $1.4B | ||
| Q3 24 | $354.1M | $726.5M | ||
| Q2 24 | $360.9M | $775.9M | ||
| Q1 24 | $377.6M | $557.8M |
负债/权益比
BBAI
RXRX
| Q4 25 | 0.17× | 0.01× | ||
| Q3 25 | 0.17× | 0.01× | ||
| Q2 25 | 0.39× | 0.02× | ||
| Q1 25 | 0.51× | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | 1.54× | 0.04× | ||
| Q2 24 | 1.45× | 0.04× | ||
| Q1 24 | 1.37× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-21.8M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-22.1M | $-47.3M |
| 自由现金流率自由现金流/营收 | -80.9% | -133.1% |
| 资本支出强度资本支出/营收 | 0.9% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-42.5M | $-378.3M |
8季度趋势,按日历期对齐
经营现金流
BBAI
RXRX
| Q4 25 | $-21.8M | $-46.1M | ||
| Q3 25 | $-9.6M | $-117.4M | ||
| Q2 25 | $-3.9M | $-76.4M | ||
| Q1 25 | $-6.7M | $-132.0M | ||
| Q4 24 | $-14.8M | $-115.4M | ||
| Q3 24 | $-1.9M | $-59.2M | ||
| Q2 24 | $-7.1M | $-82.2M | ||
| Q1 24 | $-14.4M | $-102.3M |
自由现金流
BBAI
RXRX
| Q4 25 | $-22.1M | $-47.3M | ||
| Q3 25 | $-9.8M | $-117.6M | ||
| Q2 25 | $-3.9M | $-79.6M | ||
| Q1 25 | $-6.7M | $-133.8M | ||
| Q4 24 | $-15.0M | $-116.7M | ||
| Q3 24 | $-2.0M | $-63.8M | ||
| Q2 24 | $-7.2M | $-83.4M | ||
| Q1 24 | $-14.4M | $-109.0M |
自由现金流率
BBAI
RXRX
| Q4 25 | -80.9% | -133.1% | ||
| Q3 25 | -29.5% | -2272.5% | ||
| Q2 25 | -11.9% | -413.9% | ||
| Q1 25 | -19.4% | -907.4% | ||
| Q4 24 | -34.2% | -2567.7% | ||
| Q3 24 | -4.9% | -244.6% | ||
| Q2 24 | -18.1% | -578.5% | ||
| Q1 24 | -43.5% | -789.9% |
资本支出强度
BBAI
RXRX
| Q4 25 | 0.9% | 3.5% | ||
| Q3 25 | 0.6% | 4.7% | ||
| Q2 25 | 0.0% | 16.4% | ||
| Q1 25 | 0.2% | 12.4% | ||
| Q4 24 | 0.4% | 28.6% | ||
| Q3 24 | 0.3% | 17.5% | ||
| Q2 24 | 0.3% | 8.2% | ||
| Q1 24 | 0.1% | 48.2% |
现金转化率
BBAI
RXRX
| Q4 25 | — | — | ||
| Q3 25 | -3.80× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图